Drugs / tumor antigen loaded autologous dendritic cells
tumor antigen loaded autologous dendritic cells
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00197912 | Sep 2004 → Apr 2010 | melanoma | Herlev Hospital | Completed | No outcome recorded |
| Phase 1/2 | NCT00197860 | Sep 2004 → Dec 2009 | renal cell carcinoma | Inge Marie Svane | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | tumor antigen loaded autologous dendritic cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00197912 ↗ |
| Modality | Cell therapy | “vaccination with tumor antigen pulsed autologous monocyte-derived mature dendritic cells” NCT00197860 ↗ |